drugset / Trial / NCT01302925

PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects

NCT01302925

Phase 1 Completed 100 enrolled Peplin LEO Pharma · collab
RandomizedParallel-groupOpen-label

Summary

The purpose of this phase 1 trial is to investigate the local tolerability on the finger following exposure to PEP005 Gel 0.015% or 0.05% and hand washing once daily, for 2 or 3 consecutive days.

Timeline

Start
2011-02
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject ingenol mebutate Small molecule 0.015 %
Subject ingenol mebutate Small molecule 0.05 %

Indications